Label

How We Work

Grant

Back

Print

Statens Serum Institut


October 2012
to develop an IPV vaccine adjuvanted with CAF01 that is able to promote significant dose-sparing and enhance mucosal immunity.
$158,739
28
Discovery and Translational Sciences
GLOBAL
Global Health
Copenhagen S.
http://www.ssi.dk

Visit Our Blog